![conference banner](/images/conference-banner.jpeg)
Abstract
Vasoactive regulatory and transport proteins can modify the transendothelial blood-brain barrier (BBB) transport of beta-amyloid. Dysfunction of one or more of these proteins is hypothesized to contribute to the pathogenesis of Alzheimers disease (AD). In this study we investigated superior temporal and occipital cortical sections from ten AD and ten control group brains (CG). They were examined using immunohistochemical techniques staining for β42 amyloid, APOE, VEGF and eNOS. The densities of senile plaques (SPs) and APOE, VEGF and eNOS positive capillaries in each region and in each AD and CG condition were compared using nonparametric statistical analysis. In the AD cases, there were significant negative correlations between APOE positive capillaries and β42 amyloid SPs, and positive correlations between APOE positive capillaries and VEGF and eNOS positive capillaries. These results demonstrate the increased presence of APOE activity in AD brain capillaries, and that there is a positive correlation between the expression of APOE and each of VEGF and eNOS in the capillaries of AD brains. It is possible, therefore, that the down regulation of APOE in AD brains may contribute significantly to the pathogenesis of SP lesion development by modulating brain β- amyloid burden. The specific interrelationship between APOE, VEGF and eNOS activity at the BBB requires further investigation.
Keywords: Alzheimer's disease, APOE, capillaries, blood-brain barrier, AD lesions
Current Alzheimer Research
Title: Correlation Analysis of Capillary APOE, VEGF and eNOS Expression in Alzheimer Brains
Volume: 8 Issue: 2
Author(s): J. Provias and B. Jeynes
Affiliation:
Keywords: Alzheimer's disease, APOE, capillaries, blood-brain barrier, AD lesions
Abstract: Vasoactive regulatory and transport proteins can modify the transendothelial blood-brain barrier (BBB) transport of beta-amyloid. Dysfunction of one or more of these proteins is hypothesized to contribute to the pathogenesis of Alzheimers disease (AD). In this study we investigated superior temporal and occipital cortical sections from ten AD and ten control group brains (CG). They were examined using immunohistochemical techniques staining for β42 amyloid, APOE, VEGF and eNOS. The densities of senile plaques (SPs) and APOE, VEGF and eNOS positive capillaries in each region and in each AD and CG condition were compared using nonparametric statistical analysis. In the AD cases, there were significant negative correlations between APOE positive capillaries and β42 amyloid SPs, and positive correlations between APOE positive capillaries and VEGF and eNOS positive capillaries. These results demonstrate the increased presence of APOE activity in AD brain capillaries, and that there is a positive correlation between the expression of APOE and each of VEGF and eNOS in the capillaries of AD brains. It is possible, therefore, that the down regulation of APOE in AD brains may contribute significantly to the pathogenesis of SP lesion development by modulating brain β- amyloid burden. The specific interrelationship between APOE, VEGF and eNOS activity at the BBB requires further investigation.
Export Options
About this article
Cite this article as:
Provias J. and Jeynes B., Correlation Analysis of Capillary APOE, VEGF and eNOS Expression in Alzheimer Brains, Current Alzheimer Research 2011; 8 (2) . https://dx.doi.org/10.2174/156720511795256026
DOI https://dx.doi.org/10.2174/156720511795256026 |
Print ISSN 1567-2050 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5828 |
Call for Papers in Thematic Issues
Alzheimer's Disease Drug Development
Alzheimer's disease is a progressive neurodegenerative disorder that affects millions of people worldwide. Despite decades of research, no cure or disease-modifying treatment is available yet. Therefore, the need for developing effective therapies to treat Alzheimer's disease is an urgent matter. This special issue aims to provide a comprehensive overview of ...read more
Current updates on the Role of Neuroinflammation in Neurodegenerative Disorders
Neuroinflammation is an invariable hallmark of chronic and acute neurodegenerative disorders and has long been considered a potential drug target for Alzheimer’s disease (AD) and dementia. Significant evidence of inflammatory processes as a feature of AD is provided by the presence of inflammatory markers in plasma, CSF and postmortem brain ...read more
Deep Learning for Advancing Alzheimer's Disease Research
Alzheimer's disease (AD) poses a significant global health challenge, with an increasing number of individuals affected yearly. Deep learning, a subfield of artificial intelligence, has shown immense potential in various domains, including healthcare. This thematic issue of Current Alzheimer Research explores the application of deep learning techniques in advancing our ...read more
Diagnostic and therapeutic biomarkers of dementia
Dementia affects 18 million people worldwide. Dementia is a syndrome of symptoms caused by brain disease, usually chronic or progressive, clinically characterized by multiple impairments of higher cortical functions such as memory, thinking, orientation, and learning. In addition, in the course of dementia, cognitive deficits are observed, which often hinder ...read more
![Wayfinder Image](/images/wayfinder.jpg)
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Treatment of Hypertension in Chronic Kidney Disease: Does one Size Fit All? A Narrative Review from a Nephrologist’s Perspective
Current Hypertension Reviews Uveitis in Horses, Rats and Man: What Do We Learn from Our Pets?
Current Immunology Reviews (Discontinued) Platelet Activation in Atherogenesis Associated with Low-Grade Inflammation
Inflammation & Allergy - Drug Targets (Discontinued) Human Immunodeficiency Virus (HIV) and Stroke: Targets for Intervention
Infectious Disorders - Drug Targets Vascular Damage in Impaired Glucose Tolerance: An Unappreciated Phenomenon?
Current Pharmaceutical Design Plasma Ghrelin Levels in Patients with Familial Mediterranean Fever
Protein & Peptide Letters Does Diffusion Restriction Pattern on MRI Predict Stroke Etiology in a Cancer Patient?
Current Medical Imaging Neuropeptide/Receptor Expression and Plasticity in Micturition Pathways
Current Pharmaceutical Design Nanobiotechnology-based Drug Delivery in Brain Targeting
Current Pharmaceutical Biotechnology Can Drug Effects Help Elucidate the Pathogenesis of SLE?
Current Rheumatology Reviews Anti-Inflammatory Drugs and Statins for Arterial Stiffness Reduction
Current Pharmaceutical Design HCV-Related Rheumatic Manifestations and Therapeutic Strategies
Current Drug Targets Cardiovascular Complications of HIV Infection and Treatment
Cardiovascular & Hematological Agents in Medicinal Chemistry Drugs, Trials and Pathogenesis: Will Connecting these Help us Understand SLE?
Current Rheumatology Reviews Regulatory Roles of the Ubiquitin-Proteasome System in Cardiomyocyte Apoptosis
Current Molecular Medicine Systemic Inflammation Induces Endothelial Dysfunction in Peritoneal Dialysis Patients
Vascular Disease Prevention (Discontinued) Refractory Behçet’s Disease with Multi-organ Involvement - Learning from Failure
Current Rheumatology Reviews The Role of Cytokines in T Help Responses to Viruses
Current Immunology Reviews (Discontinued) Pathobiology of Pulmonary Arterial Hypertension
Current Respiratory Medicine Reviews The Role of Ubiquitin E3 Ligase in Atherosclerosis
Current Medicinal Chemistry